We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MO icon
301
Altria Group
MO
$115B
$2.79M 0.05%
38,726
+958
+3% +$66.9K
RUN icon
302
Sunrun
RUN
$2.06B
$2.77M 0.05%
206,696
+155,832
+306% +$2.1M
LOW icon
303
Lowe's Companies
LOW
$110B
$2.74M 0.05%
12,422
+3,158
+34% +$717K
TARS icon
304
Tarsus Pharmaceuticals
TARS
$3.71B
$2.73M 0.05%
43,405
-25,530
-37% -$1.63M
PJT icon
305
PJT Partners
PJT
$4.17B
$2.71M 0.05%
17,935
-9,842
-35% -$1.52M
BHRB icon
306
Burke & Herbert Financial Services Corp
BHRB
$1.44B
$2.69M 0.05%
37,464
+26,332
+237% +$1.7M
MCD icon
307
McDonald's
MCD
$179B
$2.69M 0.05%
9,955
+4,374
+78% +$1.25M
CHWY icon
308
Chewy
CHWY
$8.22B
$2.68M 0.05%
136,148
-158,498
-54% -$3.6M
MTZ icon
309
MasTec
MTZ
$19.3B
$2.66M 0.05%
6,391
-12,537
-66% -$4.79M
KVUE icon
310
Kenvue
KVUE
$34.2B
$2.64M 0.05%
138,300
-91,585
-40% -$1.61M
CMI icon
311
Cummins
CMI
$76.6B
$2.63M 0.05%
3,692
-10,659
-74% -$7.02M
ADI icon
312
Analog Devices
ADI
$184B
$2.63M 0.05%
6,617
+2,225
+51% +$881K
ABVX
313
Abivax
ABVX
$10.4B
$2.63M 0.05%
19,715
-54,011
-73% -$6.11M
AIG icon
314
American International
AIG
$39.4B
$2.6M 0.05%
+34,844
New +$2.65M
CENX icon
315
Century Aluminum
CENX
$4.36B
$2.58M 0.05%
56,016
-8,868
-14% -$533K
CMRE icon
316
Costamare
CMRE
$1.85B
$2.55M 0.05%
181,610
-102,662
-36% -$1.68M
SPHR icon
317
Sphere Entertainment
SPHR
$5.15B
$2.51M 0.05%
14,493
-27,287
-65% -$3.8M
ULCC icon
318
Frontier Group Holdings
ULCC
$1.29B
$2.47M 0.05%
+312,699
New +$1.61M
BA icon
319
Boeing
BA
$166B
$2.43M 0.04%
11,247
-3,048
-21% -$678K
HAPN
320
Happen Inc
HAPN
$1.94B
$2.43M 0.04%
+117,381
New +$2M
GFI icon
321
Gold Fields
GFI
$40.2B
$2.42M 0.04%
+72,055
New +$3M
PGY icon
322
Pagaya Technologies
PGY
$1.67B
$2.41M 0.04%
131,848
-148,298
-53% -$2.1M
HLI icon
323
Houlihan Lokey
HLI
$9.55B
$2.4M 0.04%
17,925
-9,366
-34% -$1.38M
GS icon
324
Goldman Sachs
GS
$300B
$2.38M 0.04%
2,350
+1,436
+157% +$1.4M
PIPR icon
325
Piper Sandler
PIPR
$5.4B
$2.37M 0.04%
+32,802
New +$2.66M
11 12
13
14 15

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.